ストックスクリーナーアプリを入手
10.04
0.10%
0.010
アフターアワーズ：
10.04
前日終値:
$10.03
開ける：
$10.04
24時間の取引高:
2,113
Relative Volume:
0.01
時価総額：
$639.55M
収益：
-
当期純損益:
$4.19M
株価収益率:
154.46
EPS:
0.065
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.10%
1か月 パフォーマンス:
+0.35%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.04
$10.04
1週間の範囲:
$10.02
$10.04
52週間の値動き範囲:
$9.87
$10.04
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
名前
Drugs Made In America Acquisition Ii Corp
セクター
電話
954-870-3104
住所
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, EVAC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.04 | 638.91M | 0 | 4.19M | 0 | 0.065 |
LION
Lionsgate Studios Corp
|
12.43 | 3.64B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.62 | 2.69B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
13.66 | 690.62M | 11.20M | -19.19M | -23.24M | -0.7527 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.17 | 593.25M | 0 | 8.92M | 0 | 0.1519 |
Drugs Made In America Acquisition Ii Corp (DMII) 最新ニュース
Pfizer Inc. - Britannica
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Vector Science and Therapeutics Corp.: Performance & Quotes, PAIN Stock Price on Toronto S.E. Exchange - marketscreener.com
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Talon Resources plc Stock (TAR)Quote London S.E. - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Beng Kuang Marine Receives SGX Approval for Listing of 57 Million New Shares for Asian Sealand Acquisition - Minichart
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
DRUMMOND VEN: Performance & Quotes, MACK Stock Price on Toronto S.E. Exchange - marketscreener.com
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Mid Cap Momentum - Newser
DMIIR Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
AlphaTON Capital Corp. (ALP) - Minichart
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
Centiel AG: Shareholders Board Members Managers and Company Profile | CH0024666528 - marketscreener.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành
Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition Ii Corp (DMII) 財務データ
収益
当期純利益
現金流量
EPS
5.47%
0.20%
大文字化:
|
ボリューム (24 時間):